FOR HEALTHCARE PROFESSIONALS ONLY

This website is a global information resource. It is intended for healthcare professionals only outside of the United States of America (US) who are interested in information on Foundation Medicine®. This site is not intended to provide medical advice and/or treatment guidance. If you are a US healthcare professional click here.

This site is produced by Roche as a partner of Roche Foundation Medicine.

Orange

 

 

 

Our service for diagnostic, prognostic and predictive insights to support treatment of haematological malignancies and sarcomas.1

DNA and RNA  sequencing    Uses both DNA and RNA  sequencing for sensitive detection  of translocations and fusions    1 >400 genes,  TMB, MSI    Analyses >400  cancer-related genes and   reports TMB and MSI 1
Order

Order FoundationOne Heme

Accepted specimen types are peripheral whole blood, bone marrow aspirate, FFPE block or slides, or extracted nucleic acid. Blood and bone marrow aspirate must be received the day after collection for optimal analysis.2 Some countries may not be able to offer the FoundationOne Heme service at present. We are working to make FoundationOne Heme more broadly available.

FFPE, formalin-fixed paraffin-embedded. MSI, microsatellite instability. TMB, tumour mutational burden.
References
  1. FoundationOne®Heme Technical Specifications, 2017. Available at: www.foundationmedicine.com/genomic-testing/foundation-one-heme (Accessed March 2019).
  2. FoundationOne®Heme Specimen Instructions, 2017. Available at: www.foundationmedicine.com/genomic-testing/foundation-one-heme (Accessed March 2019).